Table 1.
Framingham Risk Score (FRS) [10] | Atherosclerosis in communities (ARIC) [11] | Atherosclerosis in communities with c IMT measurement (ARIC IMT) [12] | HeartSCORE (SCORE) [13] | Reynolds Risk Score (RSS) [14,15] | QRisk2 [16] | PROCAM [17] | |
Derivation study | Framingham cohort | Atherosclerosis in communities cohort | Atherosclerosis in communities cohort | Pooled European cohorts | Pooled cohorts | Prospective nonrandomized database | MONICA cohort |
Statistical method | Cox | Cox | Cox | Weibull / Cox | Cox | Cox | Weibull |
Discrimination AUROC | 0,733 to 0,788 | 0,695 to 0842 | 0,755 | 0,70 to 0,84 | 0,708 - 0,808 | 0,792 | N/A |
Sample size | 8491 | 14054 | 14054 | 205178 | 27124 | 1535583 | 26975 |
Starting year | 1968 | 1987 | 1987 | 1972 | 1992 | 1993 | 1978 |
Number of variables | 8 | 9 | 10 | 6 | 8 | 14 | 9 |
Notoriety | Guideline | No | No | Guideline | No | No | No |
Age of participants mean (extremes) | 48,5 to 49.1 (30-75) | 54 (45 to 64) | 54 (45 to 64) | (19-80) | 45 + | 48,5 (35-75) | 45,7 (20-78) |
Outcome measured | CVD Hard | CVD | CVD | CVD Mortality | CVD hard | CVD | CVD Hard |
RA specific | No | No | No | No | No | Yes | No |
Ease of use | Clinical + lab | Clinical + lab | Clinical, lab, ultrasound | Clinical, Lab | Clinical, Lab | Clinical, Lab | Clinical, Lab |
Country | US | US | US | Europe | US | UK | Germany |
Calculator available | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
10 year risk estimates | percentage | percentage | percentage | percentage | percentage | percentage | percentage |
Calculator risk categories | <5%, 5- 10%, 10-20%, >20% | <5%, 5- 10%, 10-20%, >20% | <5%, 5- 10%, 10-20%, >20% | <5%, 5-9%, 10-15% > 15% | <5%, 5- 10%, 10-20%, >20% | <5%, 5- 10%, 10-20%, >20% | <10%, 10-20%,>20% |
RA Validation | yes | no | no | yes | yes | yes | yes |